Aridis Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $1.58 | $1.58 | $1.58 |
| Q2 2024 | 1 | $1.34 | $1.34 | $1.34 |
| Q3 2024 | 1 | $1.54 | $1.54 | $1.54 |
Aridis Pharmaceuticals, Inc. Earnings Date And Information
Aridis Pharmaceuticals, Inc. last posted its earnings results on Monday, November 6th, 2023. The company reported $-0.02 earnings per share for the quarter, missing analysts' consensus estimates of $-0.01 by $0.01. The company had revenue of 417,000 for the quarter and had revenue of 0 for the year. Aridis Pharmaceuticals, Inc. has generated $-2 earnings per share over the last year ($-1.64 diluted earnings per share) and currently has a price-to-earnings ratio of 0. Aridis Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 21st, 2024 based on prior year's report dates.
Aridis Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2023 | Q3 2023 | -$0.01 | -$0.00 | 0.01 | $1.50 M | $417,000 |
| 09/13/2023 | Q2 2023 | $0.34 | $19.65 M | |||
| 06/08/2023 | Q1 2023 | -$0.24 | $0 | |||
| 05/22/2023 | Q4 2022 | -$0.24 | $0 | |||
| 11/21/2022 | Q3 2022 | -$0.15 | -$0.51 | -0.36 | $0 | |
| 08/15/2022 | Q2 2022 | -$0.06 | -$0.46 | -0.4 | $292,000 | |
| 05/16/2022 | Q1 2022 | -$0.51 | -$0.46 | 0.05 | $0 | |
| 04/13/2022 | Q4 2021 | -$0.71 | $570,000 | |||
| 11/10/2021 | Q3 2021 | -$0.54 | -$1.69 | -1.15 | $98,000 | |
| 08/12/2021 | Q2 2021 | -$0.57 | -$0.49 | 0.08 | $33,000 | |
| 05/11/2021 | Q1 2021 | -$0.60 | -$0.67 | -0.07 | $0 | |
| 03/30/2021 | Q4 2020 | -$0.54 | -$0.59 | -0.05 | $0 | |
| 11/23/2020 | Q3 2020 | -$0.65 | $0 | |||
| 08/11/2020 | Q2 2020 | -$0.72 | -$0.47 | 0.25 | $1.00 M | |
| 05/12/2020 | Q1 2020 | -$0.62 | -$0.73 | -0.11 | $0 | |
| 04/08/2020 | Q4 2019 | -$0.81 | -$0.63 | 0.18 | $-1,022,000 | |
| 11/13/2019 | Q3 2019 | -$0.86 | -$0.87 | -0.01 | $0 | |
| 08/12/2019 | Q2 2019 | -$1.09 | -$1.03 | 0.06 | $0 | |
| 05/14/2019 | Q1 2019 | -$0.82 | -$0.99 | -0.17 | $1.02 M | |
| 03/28/2019 | Q4 2018 | -$1.13 | -$0.67 | 0.46 | $1.39 M |
Aridis Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Aridis Pharmaceuticals, Inc.'s earnings date?
Aridis Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 21st, 2024 based off last year's report dates.
-
How can I listen to Aridis Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Aridis Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Aridis Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Aridis Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much profit does Aridis Pharmaceuticals, Inc. generate each year?
Aridis Pharmaceuticals, Inc. (:ARDS) has a recorded net income of $0. Aridis Pharmaceuticals, Inc. has generated $-1.64 earnings per share over the last four quarters.
-
What is Aridis Pharmaceuticals, Inc.'s price-to-earnings ratio?
Aridis Pharmaceuticals, Inc. (:ARDS) has a price-to-earnings ratio of 0 and price/earnings-to-growth ratio is 0.
